Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SUPRAFLEX CRUZPost-Market Clinical Follow-up Study

NCT05617599 is registered in ClinicalTrials.gov with Fundación EPIC as lead sponsor.

NCT NCT05617599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05617599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SUPRAFLEX CRUZPost-Market Clinical Follow-up Study
Lead sponsor
Fundación EPIC
Phase
Observational
Overall status
Recruiting
Start date
May 10, 2023
Completion date
December 1, 2026
Enrollment
508 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad), ischemic heart disease